Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study

Affiliations

• ¹ Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
• ² Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
• ³ Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
• ⁴ Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
• ⁵ Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
• ⁶ Comprehensive Cancer Center, National Center for Global Health and Medicine, Tokyo, Japan.
• ⁷ Department of Medical Oncology, Hamamatsu University School of Medicine, Shizuoka, Japan.
• ⁸ Tokai Central Hospital, Kakamigahara, Japan.
• ⁹ Department of Oncology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.